2.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TPST Giù?
Forum
Previsione
Frazionamento azionario
Tempest Therapeutics Inc Borsa (TPST) Ultime notizie
Will Tempest Therapeutics Inc. stock recover after earnings2025 Volume Leaders & Low Volatility Stock Suggestions - mfd.ru
How cyclical is Tempest Therapeutics Inc.’s revenue streamEarnings Performance Report & Smart Swing Trading Techniques - mfd.ru
Tempest lays out strategic plan to advance recently acquired dual-targeting CAR-T assets - marketscreener.com
Tempest Therapeutics outlines plans for acquired CAR T assets - BioWorld MedTech
Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline - TipRanks
Tempest Therapeutics, Inc. Updates on Oncology Pipeline and Clinical Progress - TradingView
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets - GlobeNewswire
TPST News Today | Why did Tempest Therapeutics stock go down today? $TPST - MarketBeat
Key facts: Tempest Therapeutics announces management changes; issues warrants - TradingView
Tempest Therapeutics Signs Warrant Agreement With Computershare - TradingView
Tempest Therapeutics (NASDAQ: TPST) closes CAR T acquisition and names new CEO - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Tempest Therapeutics completes acquisition of CAR-T assets By Investing.com - Investing.com Nigeria
Tempest Therapeutics completes acquisition of CAR-T assets - Investing.com
Tempest Therapeutics Closes All-Stock Transaction to Acquire Next-Generation CAR-T Assets and Appoints Matt Angel as CEO - Quiver Quantitative
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets - GlobeNewswire
Cancer biotech Tempest retools around dual CAR-Ts and new CEO - Stock Titan
Tempest Therapeutics (TPST) Price Target Increased by 22.22% to 11.22 - Nasdaq
Tempest Therapeutics Announces New Leadership and Acquisition - MSN
Will Tennessee Valley Authority benefit from AI trendsMarket Sentiment Summary & Weekly High Momentum Picks - baoquankhu1.vn
What’s the outlook for Tempest Therapeutics Inc.’s sectorPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru
Tempest Therapeutics (NASDAQ: TPST) wins approval for rights plan, share issuance and equity pool - Stock Titan
Investment Report: Is Tempest Therapeutics Inc stock a value trapJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn
Aug Decliners: Is Tempest Therapeutics Inc stock a top performer YTD2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Tempest Therapeutics stock surges after H.C. Wainwright upgrade By Investing.com - Investing.com Australia
Tempest Therapeutics stock surges after H.C. Wainwright upgrade - Investing.com
H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target - Investing.com India
HC Wainwright & Co. Upgrades Tempest Therapeutics (TPST) - Nasdaq
Inflation Data: Will Tempest Therapeutics Inc stock recover after earningsJuly 2025 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Tempest Therapeutics Announces Record Date for Warrant Dividends Distribution Following Asset Purchase Agreement - Quiver Quantitative
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders - GlobeNewswire
Cancer drug developer Tempest to hand out 1:1 stock warrants - Stock Titan
How risky is Tempest Therapeutics Inc. stock nowCEO Change & Precise Buy Zone Tips - bollywoodhelpline.com
Will Tempest Therapeutics Inc. stock pay special dividendsJuly 2025 Institutional & Entry Point Confirmation Signals - bollywoodhelpline.com
Sentiment Review: Can Tempest Therapeutics Inc reach all time highs this yearPortfolio Update Report & Community Driven Trade Alerts - baoquankhu1.vn
Is Tempest Therapeutics Incs growth already priced inWeekly Trend Recap & Daily Profit Focused Screening - baoquankhu1.vn
Published on: 2026-01-13 20:12:45 - Bộ Nội Vụ
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance By Investing.com - Investing.com Canada
Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting - TipRanks
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance - Investing.com India
Tempest Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Why retail investors favor Tempest Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - Улправда
Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Update & Fast Momentum Stock Entry Tips - Улправда
Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent
Market Outlook: Will Tempest Therapeutics Inc stock pay special dividendsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - moha.gov.vn
Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga
Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com
How sustainable is Tempest Therapeutics Inc. stock dividend payout2025 Winners & Losers & Verified Momentum Stock Alerts - Улправда
Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com India
Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):